ATRC
VENTE TOTALE: 32 064 titres (~1 218 753,20 $ US)
- Insiders
- Prange Karen, Yuen Maggie, WEHRWEIN SVEN
- Total bought
- —
- Total sold
- $1,218,753
- Last activity
- 2026-08-05
- Last synced
-
2026-08-11 09:46:50
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-09-06
Despite solid liquidity (85) and a recent Q2 2026 GAAP profitability beat, the weak catalyst score (25) with no identifiable catalyst type and persistent fundamental fragility (score 45) — including negative operating…
The first sentence of the analysis written for ATRC on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 74.4% | 74.7% | 75.2% | 74.4% | 75.0% | |
| Ebit Margin | -0.8% | -8.0% | -5.7% | -12.5% | 20.2% | |
| Ebitda Margin | 3.0% | -4.0% | -2.0% | -8.9% | 24.0% | |
| Operating Profit Margin | -0.6% | -8.6% | -6.7% | -12.9% | 20.1% | |
| Pretax Profit Margin | -1.9% | -9.4% | -7.5% | -14.0% | 18.4% | |
| Continuous Operations Profit Margin | -2.1% | -9.6% | -7.6% | -14.1% | 18.3% | |
| Net Profit Margin | -2.1% | -9.6% | -7.6% | -14.1% | 18.3% | |
| Bottom Line Profit Margin | -2.1% | -9.6% | -7.6% | -14.1% | 18.3% | |
| Current Ratio | 3.956 | 3.648 | 3.570 | 3.686 | 3.474 | |
| Quick Ratio | 2.993 | 2.622 | 2.660 | 2.899 | 2.783 | |
| Solvency Ratio | 0.056 | -0.175 | -0.106 | -0.270 | 0.461 | |
| Cash Ratio | 2.054 | 1.671 | 1.131 | 0.995 | 0.773 | |
| Price To Earnings Ratio | -164.833 | -32.168 | -54.076 | -43.510 | 62.640 | |
| Price To Earnings Growth Ratio | 2.206 | -0.732 | 1.532 | 0.227 | -0.317 | |
| Forward Price To Earnings Growth Ratio | 2.206 | -0.732 | 1.532 | 0.227 | -0.317 | |
| Price To Earnings Diluted Ratio | -164.833 | -32.168 | -54.076 | -43.510 | 63.789 | |
| Price To Earnings Diluted Growth Ratio | 2.206 | -0.732 | 1.532 | 0.225 | -0.326 | |
| Price To Book Ratio | 3.840 | 3.114 | 3.545 | 4.444 | 6.477 | |
| Price To Sales Ratio | 3.534 | 3.085 | 4.140 | 6.144 | 11.422 | |
| Price To Free Cash Flow Ratio | 39.122 | -127.521 | -44.057 | -52.020 | -133.151 | |
| Price To Operating Cash Flow Ratio | 32.947 | 117.605 | 368.592 | -91.682 | -227.390 | |
| Debt To Assets Ratio | 0.135 | 0.126 | 0.121 | 0.127 | 0.123 | |
| Debt To Equity Ratio | 0.179 | 0.166 | 0.160 | 0.163 | 0.156 | |
| Debt To Capital Ratio | 0.152 | 0.142 | 0.138 | 0.140 | 0.135 | |
| Long Term Debt To Capital Ratio | 0.130 | 0.118 | 0.115 | 0.111 | 0.110 | |
| Financial Leverage Ratio | 1.330 | 1.322 | 1.317 | 1.282 | 1.272 | |
| Working Capital Turnover Ratio | 2.455 | 2.410 | 2.291 | 2.229 | 1.381 | |
| Operating Cash Flow Ratio | 0.703 | 0.166 | 0.060 | -0.379 | -0.244 | |
| Operating Cash Flow Sales Ratio | 0.107 | 0.026 | 0.011 | -0.067 | -0.050 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.842 | -0.922 | -8.366 | 1.762 | 1.708 | |
| Debt Service Coverage Ratio | 1.663 | -2.123 | -0.920 | -3.579 | 13.330 | |
| Interest Coverage Ratio | -0.586 | -6.245 | -3.853 | -8.558 | 11.225 | |
| Short Term Operating Cash Flow Coverage Ratio | 18.370 | 4.351 | 1.770 | -6.643 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.651 | 0.159 | 0.060 | -0.297 | -0.182 | |
| Capital Expenditure Coverage Ratio | 6.335 | 0.520 | 0.107 | -1.312 | -1.413 | |
| Dividend Paid And Capex Coverage Ratio | 6.335 | 0.520 | 0.107 | -1.312 | -1.413 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 111.386 | -74.947 | -202.608 | -69.364 | 48.146 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 74.4% | ▼-0.3% | ▼-0.4% |
| Ebit Margin | -0.8% | ▲7.2% | ▲0.6% |
| Ebitda Margin | 3.0% | ▲7.0% | ▲0.6% |
| Operating Profit Margin | -0.6% | ▲8.0% | ▲1.1% |
| Pretax Profit Margin | -1.9% | ▲7.5% | ▲1.0% |
| Continuous Operations Profit Margin | -2.1% | ▲7.5% | ▲0.9% |
| Net Profit Margin | -2.1% | ▲7.5% | ▲0.9% |
| Bottom Line Profit Margin | -2.1% | ▲7.5% | ▲0.9% |
| Current Ratio | 3.956 | ▲0.309 | ▲0.289 |
| Quick Ratio | 2.993 | ▲0.372 | ▲0.202 |
| Solvency Ratio | 0.056 | ▲0.231 | ▲0.063 |
| Cash Ratio | 2.054 | ▲0.382 | ▲0.729 |
| Price To Earnings Ratio | -164.833 | ▼-132.665 | ▼-118.444 |
| Price To Earnings Growth Ratio | 2.205 | ▲2.938 | ▲1.623 |
| Forward Price To Earnings Growth Ratio | 2.205 | ▲2.938 | ▲1.623 |
| Price To Earnings Diluted Ratio | -164.833 | ▼-132.665 | ▼-118.674 |
| Price To Earnings Diluted Growth Ratio | 2.205 | ▲2.938 | ▲1.625 |
| Price To Book Ratio | 3.840 | ▲0.726 | ▼-0.444 |
| Price To Sales Ratio | 3.534 | ▲0.449 | ▼-2.131 |
| Price To Free Cash Flow Ratio | 39.123 | ▲166.644 | ▲102.648 |
| Price To Operating Cash Flow Ratio | 32.947 | ▼-84.658 | ▼-7.067 |
| Debt To Assets Ratio | 0.135 | ▲0.009 | ▲0.008 |
| Debt To Equity Ratio | 0.179 | ▲0.013 | ▲0.014 |
| Debt To Capital Ratio | 0.152 | ▲0.009 | ▲0.010 |
| Long Term Debt To Capital Ratio | 0.130 | ▲0.011 | ▲0.013 |
| Financial Leverage Ratio | 1.330 | ▲0.008 | ▲0.025 |
| Working Capital Turnover Ratio | 2.455 | ▲0.045 | ▲0.302 |
| Operating Cash Flow Ratio | 0.703 | ▲0.537 | ▲0.642 |
| Operating Cash Flow Sales Ratio | 0.107 | ▲0.081 | ▲0.102 |
| Free Cash Flow Operating Cash Flow Ratio | 0.842 | ▲1.764 | ▲1.837 |
| Debt Service Coverage Ratio | 1.663 | ▲3.786 | ▼-0.012 |
| Interest Coverage Ratio | -0.586 | ▲5.659 | ▲1.017 |
| Short Term Operating Cash Flow Coverage Ratio | 18.370 | ▲14.020 | ▲14.801 |
| Operating Cash Flow Coverage Ratio | 0.651 | ▲0.492 | ▲0.573 |
| Capital Expenditure Coverage Ratio | 6.335 | ▲5.815 | ▲5.488 |
| Dividend Paid And Capex Coverage Ratio | 6.335 | ▲5.815 | ▲5.488 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 111.386 | ▲186.333 | ▲148.864 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $1.89B | $1.44B | $1.65B | $2.03B | $3.13B | |
| Enterprise value | $1.81B | $1.39B | $1.64B | $2.05B | $3.17B | |
| EV / Sales | 3.38x | 2.98x | 4.12x | 6.19x | 11.54x | |
| EV / Op. cash flow | 31.56x | 113.82x | 366.40x | -92.42x | -229.71x | |
| EV / Free cash flow | 37.48x | -123.42x | -43.80x | -52.44x | -134.51x | |
| EV / EBITDA | 111.39x | -74.95x | -202.61x | -69.36x | 48.15x | |
| Net debt / EBITDA | -4.89x | 2.49x | 1.21x | -0.56x | 0.49x | |
| Current ratio | 3.96x | 3.65x | 3.57x | 3.69x | 3.47x | |
| Income quality | -5.01x | -0.27x | -0.15x | 0.48x | -0.28x | |
| Graham number | — | — | — | — | $16 | |
| Graham net-net | $2 | $1 | $1 | $1 | $1 | |
| Tax burden | 112.6% | 102.3% | 102.0% | 100.6% | 99.6% | |
| Interest burden | 237.2% | 117.2% | 130.2% | 112.1% | 91.1% | |
| Working capital | $241.0M | $194.4M | $191.7M | $156.8M | $139.6M | |
| Invested capital | $569.8M | $533.0M | $537.2M | $473.6M | $453.6M | |
| Return on assets | -1.7% | -7.3% | -5.0% | -7.9% | 8.2% | |
| Operating ROA | -0.5% | -6.5% | -4.4% | -7.1% | 8.3% | |
| Return on tangible assets | -3.1% | -14.1% | -9.7% | -14.9% | 14.9% | |
| Return on equity | -2.3% | -9.7% | -6.5% | -10.2% | 10.4% | |
| Return on invested capital | -0.6% | -7.4% | -4.9% | -8.0% | 9.8% | |
| Return on capital employed | -0.6% | -7.5% | -4.9% | -8.1% | 9.9% | |
| Earnings yield | -0.6% | -3.1% | -1.8% | -2.3% | 1.6% | |
| Free cash flow yield | 2.6% | -0.8% | -2.3% | -1.9% | -0.8% | |
| Capex / Op. cash flow | 15.8% | 192.2% | 936.6% | -76.2% | -70.8% | |
| Capex / Depreciation | 44.1% | 125.2% | 283.5% | 144.2% | 93.4% | |
| Capex / Sales | 1.7% | 5.0% | 10.5% | 5.1% | 3.6% | |
| SG&A / Sales | 58.2% | 62.6% | 63.4% | 70.0% | 74.6% | |
| R&D / Sales | 16.9% | 20.7% | 18.5% | 17.4% | 17.7% | |
| Stock comp / Sales | 8.4% | 8.7% | 8.9% | 8.7% | 10.2% | |
| Intangibles / Total assets | 43.2% | 47.8% | 48.7% | 46.8% | 45.1% | |
| Days sales outstanding | 46d | 47d | 48d | 47d | 44d | |
| Days payables outstanding | 209d | 78d | 101d | 86d | 99d | |
| Operating cycle | 255d | 281d | 299d | 246d | 252d | |
| Cash conversion cycle | 46d | 203d | 198d | 160d | 153d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+31.6%EV / Sales ▲+13.4%EV / EBITDA ▲+248.6%EV / Op. cash flow ▼-82.258Earnings yield ▲+0.025
Profitability
Return on equity ▲+0.074Return on assets ▲+0.056Return on invested capital ▲+0.068Return on capital employed ▲+0.069Operating ROA ▲+0.060Income quality ▼-4.735Tax burden ▲+0.103
Efficiency
Days sales outstanding ▼-1.818Days payables outstanding ▲+131.622Operating cycle ▼-25.833Cash conversion cycle ▼-157.455Capex / Sales ▼-0.033R&D / Sales ▼-0.038
Balance-sheet strength
Current ratio ▲+0.309Net debt / EBITDA ▼-7.380Working capital ▲+46595000.000Invested capital ▲+36759000.000Intangibles / Total assets ▼-0.046
Change over 5 years
Valuation
Market cap ▼-39.7%EV / Sales ▼-70.7%EV / EBITDA ▲+131.3%EV / Op. cash flow ▲+261.274Earnings yield ▼-0.022
Profitability
Return on equity ▼-0.127Return on assets ▼-0.099Return on invested capital ▼-0.104Return on capital employed ▼-0.105Operating ROA ▼-0.088Income quality ▼-4.734Tax burden ▲+0.130
Efficiency
Days sales outstanding ▲+1.579Days payables outstanding ▲+110.056Operating cycle ▲+3.308Cash conversion cycle ▼-106.747Capex / Sales ▼-0.019R&D / Sales ▼-0.008
Balance-sheet strength
Current ratio ▲+0.483Net debt / EBITDA ▼-5.375Working capital ▲+101366000.000Invested capital ▲+116221000.000Intangibles / Total assets ▼-0.019
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-05-06 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-05-06 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2024-07-19 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2024-06-18 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2021-06-08 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2020-04-30 | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2020-03-31 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2020-02-21 | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 2019-11-07 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2019-06-27 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-07 Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here''s What Matters for Investors This disposition involved 3,500 shares at $38.42 per share, totaling $134,470. The transaction reduced the director''s total equity holdings by 20%, based on holdings reported in the Form 4.
- 2026-08-07 An AtriCure Director Sold $905,000 in Stock. Here''s How to Read It Karen Prange disposed of 3,564 shares for a total transaction value of approximately $138,283 on August 5. The sale resulted in a 14% reduction in the director''s total direct equity holdings in the company.
- 2026-07-31 A Look at AtriCure Inc (ATRC) After 6.0% Decline -- GF Value $39.32 vs Price $37.76 On July 31, 2026, AtriCure Inc (ATRC) shares fell 6.0% today, bringing the current price to $37.76. This price is within a 52-week range of $25.36 to $43.18, re
- 2026-07-23 AtriCure, Inc. (ATRC) Q2 2026 Earnings Call Transcript AtriCure, Inc. (ATRC) Q2 2026 Earnings Call Transcript
- 2026-07-23 AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for AtriCure (ATRC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 2026-07-23 AtriCure (ATRC) Q2 Earnings and Revenues Top Estimates AtriCure (ATRC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to a loss of $0.02 per share a year ago.
- 2026-07-23 AtriCure Q2 Earnings Call Highlights AtriCure NASDAQ: ATRC reported double-digit revenue growth and a return to GAAP profitability in the second quarter of 2026, with management pointing to strong demand across its pain management, appendage management and open ablation franchises while noting continued pressure in minimally invasive ablation.
- 2026-07-23 AtriCure Reports Second Quarter 2026 Financial Results MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2026 financial results. “Our team delivered healthy growth and a significant step up in profitability in the second quarter,” said Michael Carrel, President and Chief Executive Officer. “Our innovative technologies continue to prove their valu.
- 2026-07-02 AtriCure to Announce Second Quarter 2026 Financial Results MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its second quarter 2026 financial results on Thursday, July 23, 2026. AtriCure will host an audio webcast at 4:30 p.m. Eastern Time on Thursday, July 23, 2026, to discuss its second quarter financial results. Those interested in listeni.
- 2026-07-02 AtriCure to Announce Second Quarter 2026 Financial Results [url="]AtriCure, Inc.[/url] ([url="]Nasdaq: ATRC[/url]), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial a